Karuna Therapeutics Ownership | Who Owns Karuna Therapeutics?
Karuna Therapeutics Ownership Summary
100.00% retail investors. Ifp advisors is the largest institutional shareholder, holding 0% of KRTX shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 0.50% of its assets in Karuna Therapeutics shares.
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ifp advisors | - | - | - |
| Eversource wealth advisors | - | - | - |
| Sachetta | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ifp advisors | - | - | - |
| Eversource wealth advisors | - | - | - |
| Sachetta | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sachetta | - | - | -1.00 |
| Eversource wealth advisors | - | - | -88.00 |
| Ifp advisors | - | - | -817.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ifp advisors | - | - | -817.00 |
| Eversource wealth advisors | - | - | -88.00 |
| Sachetta | - | - | -1.00 |
Sold Out
| Holder | Change |
|---|---|
| Sachetta | -1.00 |
| Eversource wealth advisors | -88.00 |
| Ifp advisors | -817.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2024 | 3 | -99.16% | 906 | -100.00% | - | - | - | -100.00% | 1 | -98.89% |
| Dec 31, 2023 | 359 | 31.02% | 37,214,897 | -1.67% | 100 | 1.00% | 219 | 65.91% | 90 | 2.27% |
| Sep 30, 2023 | 274 | -11.90% | 37,848,839 | 0.53% | 100 | 1.00% | 132 | -21.43% | 88 | -4.35% |
| Jun 30, 2023 | 311 | 18.70% | 37,647,946 | -2.63% | 100 | 0.81% | 168 | 12.75% | 92 | 27.78% |
| Mar 31, 2023 | 262 | - | 38,663,544 | 11.66% | 111 | 1.10% | 149 | 2.76% | 72 | -4.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 190.00K | 0.50% | -149.84K |
| Man GLG Event Driven Alternative IN USD | 158.28K | 0.41% | 133.26K |
| Fidelity Global Innovators Cl F | 131.60K | 0.34% | -627.00 |
| BlackRock Extended Mkt Composite | 83.56K | 0.22% | 12.03K |
| Arbitrage R | 79.08K | 0.21% | 79.08K |
| The Merger Fund A | 74.14K | 0.19% | 74.14K |
| UBS (Lux) EF Biotech (USD) P-acc | 69.72K | 0.18% | -1.08K |
| T. Rowe Price US Smlr Cm Eq A USD | 61.85K | 0.16% | 5.12K |
| Allspring (Lux) WW At Rk Pr I USD Acc | 60.82K | 0.16% | 20.03K |
| TD US Mid-Cap Growth - I | 45.39K | 0.12% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 08, 2024 | Brannan Stephen K. | Chief Medical Officer | Sell | $31.90K |
| Mar 08, 2024 | Brannan Stephen K. | Chief Medical Officer | Sell | $1.56M |
| Feb 08, 2024 | Brannan Stephen K. | Chief Medical Officer | Sell | $1.32M |
| Feb 08, 2024 | Brannan Stephen K. | Chief Medical Officer | Sell | $258.95K |
| Jan 08, 2024 | Brannan Stephen K. | Chief Medical Officer | Sell | $4.75M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q1 | - | 5 |
| 2023 Q4 | - | 12 |
| 2023 Q3 | - | 26 |
| 2023 Q2 | - | 10 |
| 2023 Q1 | - | 7 |
KRTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools